The present invention relates to pharmaceutical compositions of Febuxostat in the crystalline form F10 obtainable by wet granulation comprising a granular phase with granules and an extragranular phase wherein the wherein the percentage of the granules is 70 weight-% or more relative to the total weight of the composition, the composition being flexible towards the interchange of crystalline form F10 into other modifications of Febuxostat such as form II, form G or form A.